Starting with Duchenne muscular dystrophy, Exonics is translating SingleCut CRISPR gene editing technology into therapies for genetic neuromuscular diseases with significant unmet need. We worked with Exonics to design a logo that intertwined the concepts of gene therapy with growth and thriving. The Exonics website combines compelling images of boys at different stages of development, with branded infographics illustrating the role of dystrophin, Exonics’ SingleCut CRISPR technology, how gene repair works, and the progress being made in this important work.
